The FDA has identified cases of serious liver injury among patients being treated for primary biliary cholangitis with Ocaliva (obeticholic acid) who did not have cirrhosis of the liver. Learn more about the Ocaliva drug safety communication
New York
New York
United States
© Prepping Communities. This content is for informational purposes only and not professional advice. Use at your own risk.
Terms | Privacy | Guidelines